Europe PMCレビュー膵がん
Precision Oncology in Hepatopancreatobiliary Cancer Surgery.
原典を開く 追跡可能な記録
01
抄録
Advances in technology have allowed for the characterization of tumors at the genomic, transcriptomic, and proteomic levels. There are well-established targets for biliary tract cancers, with exciting new targets emerging in pancreatic ductal adenocarcinoma and potential targets in hepatocellular carcinoma. Taken together, these data suggest an important role for molecular profiling for personalizing cancer therapy in advanced disease and need for design of novel neoadjuvant studies to leverage these novel therapeutics perioperatively in the surgical patient.
02
索引化された箇所
検索結果は論文との関係を保ちながら、これらの検索単位を参照します。
この記録はまだハイブリッドインデックスに含まれていません。